Type 1 diabetes, Secondary diabetes, gestational diabetes
Ongoing dementia treatment or anti-depressive disorder medication
Uncontrolled psychiatric disorder
BDI = 30 points
Heavy alcoholics
Underlying chronic liver disease (hemochromatosis, liver cell carcinoma, autoimmune liver disease, liver cirrhosis, chronic viral hepatitis)
Allergy or hypersensitivity to target medication or any of its components
Renal failure, moderate or severe renal impairment (estimated glomerular filtration rate < 30 mL/min/1.73 m2), or ongoing dialysis
Abnormal liver function (AST/ALT > x3 upper normal limit)
History of alcohol or drug abuse in the previous 3 months
Premenopausal women who are nursing or pregnant
Human immunodeficiency virus (HIV) or human immunodeficiency virus (AIDS)
chronic pancreatitis or pancreatic cancer

NCT03059069_exc_T1
Condition
Type 1 diabetes
NCT03059069_exc_T2
Condition
Secondary diabetes
NCT03059069_exc_T3
Condition
gestational diabetes
NCT03059069_exc_T4
Condition
dementia
NCT03059069_exc_T5
Procedure
treatment
NCT03059069_exc_T6
Drug
anti-depressive disorder medication
NCT03059069_exc_T7
Temporal
Ongoing
NCT03059069_exc_T8
Qualifier
Uncontrolled
NCT03059069_exc_T9
Measurement
BDI
NCT03059069_exc_T10
Value
= 30 points
NCT03059069_exc_T11
Qualifier
Heavy
NCT03059069_exc_T12
Condition
alcoholics
NCT03059069_exc_T13
Condition
chronic liver disease
NCT03059069_exc_T14
Condition
hemochromatosis
NCT03059069_exc_T15
Condition
liver cell carcinoma
NCT03059069_exc_T16
Condition
autoimmune liver disease
NCT03059069_exc_T17
Condition
liver cirrhosis
NCT03059069_exc_T18
Condition
chronic viral hepatitis
NCT03059069_exc_T19
Scope
hemochromatosis, liver cell carcinoma, autoimmune liver disease, liver cirrhosis, chronic viral hepatitis
NCT03059069_exc_T20
Condition
Allergy
NCT03059069_exc_T21
Condition
hypersensitivity
NCT03059069_exc_T22
Drug
target medication
NCT03059069_exc_T23
Scope
Allergy or hypersensitivity
NCT03059069_exc_T24
Condition
Renal failure
NCT03059069_exc_T25
Qualifier
moderate
NCT03059069_exc_T26
Qualifier
severe
NCT03059069_exc_T27
Condition
renal impairment
NCT03059069_exc_T28
Scope
moderate or severe
NCT03059069_exc_T29
Measurement
estimated glomerular filtration rate
NCT03059069_exc_T30
Value
< 30 mL/min/1.73 m2
NCT03059069_exc_T31
Temporal
ongoing
NCT03059069_exc_T32
Procedure
dialysis
NCT03059069_exc_T33
Scope
moderate or severe renal impairment
NCT03059069_exc_T34
Scope
estimated glomerular filtration rate < 30 mL/min/1.73 m2
NCT03059069_exc_T35
Measurement
liver function
NCT03059069_exc_T36
Value
Abnormal
NCT03059069_exc_T37
Measurement
AST/ALT
NCT03059069_exc_T38
Value
> x3 upper normal limit
NCT03059069_exc_T39
Scope
Abnormal liver function
NCT03059069_exc_T40
Scope
AST/ALT > x3 upper normal limit
NCT03059069_exc_T41
Condition
drug abuse
NCT03059069_exc_T42
Condition
r drug the p
NCT03059069_exc_T43
Temporal
in the previous 3 months
NCT03059069_exc_T44
Scope
alcohol or drug abuse
NCT03059069_exc_T45
Condition
Premenopausal
NCT03059069_exc_T46
Person
women
NCT03059069_exc_T47
Condition
nursing
NCT03059069_exc_T48
Condition
pregnant
NCT03059069_exc_T49
Condition
Human immunodeficiency virus (HIV)
NCT03059069_exc_T50
Condition
human immunodeficiency virus (AIDS)
NCT03059069_exc_T51
Condition
chronic pancreatitis
NCT03059069_exc_T52
Condition
pancreatic cancer